Nature
25 articles in the TruthFoundry index. Each links out to the original.
- Nature Reviews Gastroenterology & Hepatology Covers ESPEN 2026 Congress · Nature Reviews Gastroenterology & Hepatology reports on the 48th ESPEN Congress 2026 in Berlin.
- Non-Antibiotic Compounds Exhibit Antimicrobial Effects on Gut Microbiome · Research reveals non-antibiotic drugs and environmental chemicals disrupt gut bacteria and colonization resistance.
- Comment proposes strategies to build Asia gastroenterology research leadership · Asia carries high digestive disease burden but lacks global research leadership, authors note.
- CHESS-LiverHealth Study Reveals High Liver Disease Prevalence in China · A study of nearly 30,000 Chinese adults found a 43.7% prevalence of steatotic liver disease.
- Antifungal Therapy Reshapes Gut Microbiota in IBD Patients · Fluconazole alters gut mycobiome composition and bacterial diversity in inflammatory bowel disease patients.
- MATTERHORN trial shows survival benefit for gastric cancer immunotherapy · Phase III MATTERHORN trial finds durvalumab improves overall survival for resectable gastric cancer.
- Review of Intestinal Stem Cell Biology and Regeneration Mechanisms · A comprehensive review details how intestinal stem cells maintain tissue homeostasis and drive regeneration after injury.
- Exposome framework proposed for inflammatory bowel disease prevention · Academic work outlines exposome use for inflammatory bowel disease primary prevention
- Academic citations collection for occult hepatitis B virus infection research · This document compiles peer-reviewed citations on occult hepatitis B virus infection.
- Review Analyzes Combined Radiotherapy Immunotherapy For Pancreatic Cancer · Academic literature examines combined radiotherapy and immunotherapy for localized pancreatic cancer.
- Expert Perspectives on Heart-Liver Co-Management in MASLD · Experts recommend a multidisciplinary cardiometabolic framework for managing metabolic dysfunction-associated steatotic liver disease.
- Residual burden proposed as new IBD treatment target · Inflammatory bowel disease patients in remission often have unrecognized non-inflammatory symptoms.
- Paediatric hepatologists urge WHO to include children in steatotic liver disease resolution · Paediatric hepatologists argue the WHO resolution on steatotic liver disease must prioritise paediatric SLD and urge screening and food regulation.
- Long Non-Coding RNAs Shape Colorectal Cancer Microenvironment · Review details how long non-coding RNAs regulate colorectal cancer progression and the tumor microenvironment.
- Researchers Back Adding Children to Global Steatotic Liver Disease Agenda · Authors agree to include children in the global steatotic liver disease agenda and propose indicator-based pediatric MASLD screening.
- New Alliance Facilitates Global Collaboration for Chinese Liver Researchers · A new alliance aims to foster international collaboration and mentorship for the next generation of Chinese liver investigators.
- Disrupted Gut Microbiome Linked to Disease; Policy Action Urged · Scientists urge policymakers to act on the gut microbiome's role in noncommunicable diseases.
- Phase I faecal microbiome transplant trial for peanut allergy shows response in 6 of 15 · Phase I trial found faecal microbiome transplant increased peanut tolerance in 6 of 15 patients.
- Sexual Dimorphism in the Liver: Hormonal Mechanisms and Disease · Research explores how sexual selection and natural selection shape liver biology through sex hormones.
- Duvakitug Shows Efficacy in Crohn's and Ulcerative Colitis Trials · Duvakitug demonstrated efficacy versus placebo in phase IIb trials for moderate-to-severe Crohn's disease and ulcerative colitis.
- Noninvasive Imaging and Scores Replace Biopsy for MASLD Fibrosis Staging · New study finds imaging and composite scores accurately stage advanced fibrosis and cirrhosis in MASLD.
- Wetland Virus Infection Triggers Fatal Liver Damage via Pyroptosis · Wetland virus infection causes fatal liver dysfunction through gasdermin E-mediated pyroptosis and lipid accumulation in mice.
- Researcher Jelena Mann bridges gap between fibrosis discovery and patient delivery · Jelena Mann, transitioning from researcher to CEO, highlights the critical disconnect between scientific discovery and patient access.
- Global Epidemiology of Metabolic and Alcohol-Associated Liver Disease · Recent studies reveal the global burden, risk factors, and diagnostic challenges of steatotic liver disease subtypes.
- Global Experts Define Dynamic Spectrum of Steatotic Liver Disease · International council establishes new framework for understanding steatotic liver disease globally.